Your browser doesn't support javascript.
loading
Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?
Protic, Dragana; Salcedo-Arellano, Maria Jimena; Stojkovic, Maja; Saldarriaga, Wilmar; Ávila Vidal, Laura Alejandra; Miller, Robert M; Tabatadze, Nazi; Peric, Marina; Hagerman, Randi; Budimirovic, Dejan B.
Afiliação
  • Protic D; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Salcedo-Arellano MJ; Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA.
  • Stojkovic M; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute UCDHS, University of California Davis, Sacramento, CA, USA.
  • Saldarriaga W; Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA, USA.
  • Ávila Vidal LA; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Miller RM; Department of Morphology, Universidad del Valle School of Medicine, Cali, Colombia.
  • Tabatadze N; Department of Obstetrics and Gynecology, Hospital Universitario del Valle, Evaristo Garcia, Cali, Colombia.
  • Peric M; Medicine and Surgery, Universidad del Valle School of Medicine, Cali, Colombia.
  • Hagerman R; National Fragile X Foundation, McLean, VA, USA.
  • Budimirovic DB; Fragile X Center, MediClubGeorgia Medical Center, Tbilisi, Georgia.
Yale J Biol Med ; 94(4): 559-571, 2021 12.
Article em En | MEDLINE | ID: mdl-34970093
ABSTRACT
Fragile X syndrome is the most common monogenetic cause of inherited intellectual disability and syndromic autism spectrum disorder. Fragile X syndrome is caused by an expansion (full mutation ≥200 CGGs repeats, normal 10-45 CGGs) of the fragile X mental retardation 1 (FMR1) gene, epigenetic silencing of the gene, which leads to reduction or lack of the gene's product the fragile X mental retardation protein. In this cross-sectional study, we assessed general and pharmacotherapy knowledge (GK and PTK) of fragile X syndrome and satisfaction with education in neurodevelopmental disorders (NDDs) among senior medical students in Serbia (N=348), Georgia (N=112), and Colombia (N=58). A self-administered 18-item questionnaire included GK (8/18) and PTK (7/18) components and self-assessment of the participants education in NDDs (3/18). Roughly 1 in 5 respondents had correct answers on half or more facts about fragile X syndrome (GK>PTK), which ranged similarly 5-7 in Serbia, 6-8 in Georgia, and 5-8 in Colombia, respectively. No cohort had an average value greater than 9 (60%) that would represent passing score "cut-off." None of the participants answered all the questions correctly. More than two-thirds of the participants concluded that they gained inadequate knowledge of NDDs during their studies, and that their education in this field should be more intense. In conclusion, there is a major gap in knowledge regarding fragile X syndrome among senior medical students in these three developing countries. The finding could at least in part be generalized to other developing countries aimed toward increasing knowledge and awareness of NDDs and fostering an institutional collaboration between developed and developing countries.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Cromossomo X Frágil Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Colombia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Cromossomo X Frágil Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Colombia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article